| Literature DB >> 34040261 |
Stefanie Warnat-Herresthal1,2, Hartmut Schultze3, Krishnaprasad Lingadahalli Shastry3, Sathyanarayanan Manamohan3, Saikat Mukherjee3, Vishesh Garg3,4, Ravi Sarveswara3, Kristian Händler1,5, Peter Pickkers6, N Ahmad Aziz7,8, Sofia Ktena9, Monique M B Breteler7,10, Evangelos J Giamarellos-Bourboulis9, Matthijs Kox6, Matthias Becker1,5, Sorin Cheran3, Michael S Woodacre3, Eng Lim Goh3, Joachim L Schultze11,12,13, Florian Tran14,15, Michael Bitzer16, Stephan Ossowski17,18, Nicolas Casadei17,18, Christian Herr19, Daniel Petersheim20, Uta Behrends21, Fabian Kern22, Tobias Fehlmann22, Philipp Schommers23, Clara Lehmann23,24,25, Max Augustin23,24,25, Jan Rybniker23,24,25, Janine Altmüller26, Neha Mishra15, Joana P Bernardes15, Benjamin Krämer27, Lorenzo Bonaguro1,2, Jonas Schulte-Schrepping1,2, Elena De Domenico1,5, Christian Siever3, Michael Kraut1,5, Milind Desai3, Bruno Monnet3, Maria Saridaki9, Charles Martin Siegel3, Anna Drews1,5, Melanie Nuesch-Germano1,2, Heidi Theis1,5, Jan Heyckendorf27, Stefan Schreiber14, Sarah Kim-Hellmuth20, Jacob Nattermann28,29, Dirk Skowasch30, Ingo Kurth31, Andreas Keller22,32, Robert Bals19, Peter Nürnberg26, Olaf Rieß17,18, Philip Rosenstiel15, Mihai G Netea33,34, Fabian Theis35, Sach Mukherjee36, Michael Backes37, Anna C Aschenbrenner1,2,5,33, Thomas Ulas1,2.
Abstract
Fast and reliable detection of patients with severe and heterogeneous illnesses is a major goal of precision medicine1,2. Patients with leukaemia can be identified using machine learning on the basis of their blood transcriptomes3. However, there is an increasing divide between what is technically possible and what is allowed, because of privacy legislation4,5. Here, to facilitate the integration of any medical data from any data owner worldwide without violating privacy laws, we introduce Swarm Learning-a decentralized machine-learning approach that unites edge computing, blockchain-based peer-to-peer networking and coordination while maintaining confidentiality without the need for a central coordinator, thereby going beyond federated learning. To illustrate the feasibility of using Swarm Learning to develop disease classifiers using distributed data, we chose four use cases of heterogeneous diseases (COVID-19, tuberculosis, leukaemia and lung pathologies). With more than 16,400 blood transcriptomes derived from 127 clinical studies with non-uniform distributions of cases and controls and substantial study biases, as well as more than 95,000 chest X-ray images, we show that Swarm Learning classifiers outperform those developed at individual sites. In addition, Swarm Learning completely fulfils local confidentiality regulations by design. We believe that this approach will notably accelerate the introduction of precision medicine.Entities:
Year: 2021 PMID: 34040261 DOI: 10.1038/s41586-021-03583-3
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962